マラリアを治療するためにタンパク質合成を抑制する
1Department of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX, USA.
まとめ
コヴァラント性プロドラッグは,寄生虫のタンパク質合成を選択的に標的とし抑制し,その死に至る. この革新的なアプローチはヒトの細胞を助長し 寄生虫感染に対する有望な治療策となります
科学分野:
- 薬剤化学
- 寄生虫学
- 分子生物学
背景:
- 寄生虫感染は 世界的に大きな健康問題となっています
- 既存の治療法には 毒性や耐性などの 限界があります
- 重要な寄生虫の経路をターゲットにすることで 選択的な治療法への道が開けます
研究 の 目的:
- 新種の共性前薬を開発する
- 寄生虫のタンパク質合成に対するこれらの前薬の作用機構を調査する.
- 寄生虫とヒトの細胞に対する 前薬の選択性と有効性を評価する.
主な方法:
- 新型共性前薬の合成と特徴付け
- 寄生虫のタンパク質合成の抑制を測定する in vitro 測定法
- 寄生虫とヒトの細胞系における細胞毒性を評価するための細胞ベースの測定法.
- 関連する寄生虫感染モデルにおける in vivo 研究
主要な成果:
- 開発された共性前薬は,寄生虫のタンパク質合成を効果的に抑制した.
- 寄生虫の選択的殺戮は,ヒトの細胞に最小限の影響を及ぼすと観察されました.
- プロドラッグは臨床前モデルで強力な抗寄生作用を示した.
結論:
- 寄生病の治療には 有望な戦略です
- 選択的共性阻害剤によるタンパク質合成をターゲットにすることで,安全で効果的な治療法が提供されます.
- これらの化合物のさらなる開発は,新しい抗寄生剤につながる可能性があります.
関連する概念動画
Types of RNA
67.1K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
67.1K
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Drugs that Destabilize Microtubules
2.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
Combined Effects of Drugs: Synergism
4.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.9K
The Electron Transport Chain
17.5K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.5K


